Telomir Pharmaceuticals, Inc.
SEC Filing List
CIK: 0001971532
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 10/06/2026 | |
| 8-K | Current report filing | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 09/17/2026 | |
| 8-K | Current report filing | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 09/16/2026 | |
| 8-K | Current report filing | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 09/14/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 08/19/2026 | |
| SCHEDULE 13G/A | Toppan Merrill/FA | 08/14/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 08/13/2026 | |
| 8-K | Current report filing | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 08/10/2026 | |
| DEF 14A | Definitive proxy statements | Telomir Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 07/28/2026 | |
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | M2 COMPLIANCE LLC /fa | 07/27/2026 | |
| No record found. | |||||
| Load More | |||||
